New Annual Report Reveals Opportunity for Pharma Marketers to Reach Physicians Throughout Entire Decision-Making Journey—From Learning and Workflow Moments to PointNew Annual Report Reveals Opportunity for Pharma Marketers to Reach Physicians Throughout Entire Decision-Making Journey—From Learning and Workflow Moments to Point

Point-of-Care Is Just the Beginning: Doceree 360 Report Maps Three Strategic Imperatives for HCP Engagement Across All Digital Touchpoints

New Annual Report Reveals Opportunity for Pharma Marketers to Reach Physicians Throughout Entire Decision-Making Journey—From Learning and Workflow Moments to Point-of-Care and Beyond

SHORT HILLS, N.J., Dec. 22, 2025 /PRNewswire/ — Pharmaceutical marketers now have unprecedented opportunities to engage healthcare professionals (HCPs) across their entire digital decision-making journey, according to Doceree 360: Understanding HCP Engagement in the Age of AI (2025 Edition), released today by Doceree, the only AI-powered operating system for healthcare marketing.

The report identifies a transformative evolution in physician behavior: HCPs now make clinical decisions across a continuum of digital environments—including medical knowledge platforms, professional networks, CME environments, EHR workflows, and point-of-care systems. This creates powerful new opportunities for pharma brands to deliver relevant intelligence at every stage of the clinical journey.

We’re witnessing an expansion of engagement possibilities that didn’t exist even two years ago,” said Harshit Jain, MD, Founder and Global CEO, Doceree. “HCPs engage with clinical information before, during, and after patient interactions—across learning contexts, workflow environments, professional conversations, and point of care. Pharma marketing can now follow that journey with precision. True impact comes from reinforcing relevance across the entire decision-making arc, creating value at every meaningful touchpoint.

Three Strategic Imperatives for Pharma

The Doceree 360 report outlines three critical strategic imperatives that pharma brands must adopt to maximize impact across the complete HCP digital ecosystem:

Imperative 1: Establish a New Standard for Credible AI Content
The report highlights that HCPs no longer accept AI that is fast but unreliable. Pharma must move from content distribution to AI-governed content assurance, ensuring all AI-generated outputs are evidence-backed, auditable, and aligned with approved clinical and regulatory frameworks. Credibility, not speed alone, is now the currency of influence in HCP engagement.

Imperative 2: Deliver Context-First Engagement Across Touchpoints
HCP engagement has shifted from linear learning to adaptive, moment-driven interactions across research, learning, workflow, and conversational environments. Rather than pursuing omnipresence, the report emphasizes that pharma must focus on appearing only when the cognitive moment demands it, delivering relevant intelligence seamlessly within clinical workflows, including point-of-care and EHR environments.

Imperative 3: Shift from Promotion to Patient-Impact Enablement
As AI accelerates clinical decision-making, operational barriers such as access, affordability, and prior authorization have become more visible—and less tolerable. The Doceree 360 report shows that HCPs increasingly reward brands that help remove friction in real time, enabling faster treatment initiation and improved patient outcomes. Patient-impact enablement, not promotional messaging, is emerging as the new benchmark for engagement.

What’s Next: 2026-27 Predictions

Based on these imperatives, Doceree 360 predicts that the next phase of pharma marketing will be defined by:

  • Deeper integration of EHR- and workflow-triggered messaging delivering real-time clinical intelligence
  • AI-driven orchestration that seamlessly coordinates engagement across multiple HCP platforms
  • Advanced creative intelligence with real-time performance measurement and optimization
  • Ecosystem-led strategies that replace traditional channel-led planning with holistic journey mapping

The opportunity before us is to meet physicians wherever they are in their clinical journey—from the first learning moment to point of care and the final prescribing decision,” said Kamya Elawadhi, Chief Client Officer, Doceree. “The brands that win will be those that understand HCP engagement as a comprehensive journey across all digital touchpoints. Success requires strategic presence and precision across the full continuum where physicians learn, decide, and act.

Download the full report: https://info.doceree.com/healthcare-marketing-trends-2025-2026

About Doceree

Doceree is the only AI-powered operating system for healthcare marketing. We believe the role of AI is to bring richer context to every HCP interaction. Hence, our patented AI understands multiple layers of context to enhance every HCP interaction in a privacy-compliant manner, delivering measurably better outcomes every time. In just five years, we have emerged as leaders in AI-powered, hyper-personalized healthcare messaging — redefining HCP engagement with more powerful context and more powerful outcomes.

Photo: https://mma.prnewswire.com/media/2850450/Doceree_360_Report_Point_of_Care.jpg
Logo: https://mma.prnewswire.com/media/1758952/5592362/Doceree_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/point-of-care-is-just-the-beginning-doceree-360-report-maps-three-strategic-imperatives-for-hcp-engagement-across-all-digital-touchpoints-302647978.html

SOURCE Doceree

Market Opportunity
Nowchain Logo
Nowchain Price(NOW)
$0.00172
$0.00172$0.00172
-2.82%
USD
Nowchain (NOW) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Top Altcoins To Hold Before 2026 For Maximum ROI – One Is Under $1!

Top Altcoins To Hold Before 2026 For Maximum ROI – One Is Under $1!

BlockchainFX presale surges past $7.5M at $0.024 per token with 500x ROI potential, staking rewards, and BLOCK30 bonus still live — top altcoin to hold before 2026.
Share
Blockchainreporter2025/09/18 01:16
Robert W. Baird & Co. Discloses Core AI Design Parameters and Launches Public Testing of Baird NEUROFORGE™ Equity AI

Robert W. Baird & Co. Discloses Core AI Design Parameters and Launches Public Testing of Baird NEUROFORGE™ Equity AI

New York, United States (PinionNewswire) — Robert W. Baird & Co. (“Baird”) today announced the public disclosure of selected core system design parameters of its
Share
AI Journal2025/12/23 02:16
Best Crypto to Buy as Saylor & Crypto Execs Meet in US Treasury Council

Best Crypto to Buy as Saylor & Crypto Execs Meet in US Treasury Council

The post Best Crypto to Buy as Saylor & Crypto Execs Meet in US Treasury Council appeared on BitcoinEthereumNews.com. Michael Saylor and a group of crypto executives met in Washington, D.C. yesterday to push for the Strategic Bitcoin Reserve Bill (the BITCOIN Act), which would see the U.S. acquire up to 1M $BTC over five years. With Bitcoin being positioned yet again as a cornerstone of national monetary policy, many investors are turning their eyes to projects that lean into this narrative – altcoins, meme coins, and presales that could ride on the same wave. Read on for three of the best crypto projects that seem especially well‐suited to benefit from this macro shift:  Bitcoin Hyper, Best Wallet Token, and Remittix. These projects stand out for having a strong use case and high adoption potential, especially given the push for a U.S. Bitcoin reserve.   Why the Bitcoin Reserve Bill Matters for Crypto Markets The strategic Bitcoin Reserve Bill could mark a turning point for the U.S. approach to digital assets. The proposal would see America build a long-term Bitcoin reserve by acquiring up to one million $BTC over five years. To make this happen, lawmakers are exploring creative funding methods such as revaluing old gold certificates. The plan also leans on confiscated Bitcoin already held by the government, worth an estimated $15–20B. This isn’t just a headline for policy wonks. It signals that Bitcoin is moving from the margins into the core of financial strategy. Industry figures like Michael Saylor, Senator Cynthia Lummis, and Marathon Digital’s Fred Thiel are all backing the bill. They see Bitcoin not just as an investment, but as a hedge against systemic risks. For the wider crypto market, this opens the door for projects tied to Bitcoin and the infrastructure that supports it. 1. Bitcoin Hyper ($HYPER) – Turning Bitcoin Into More Than Just Digital Gold The U.S. may soon treat Bitcoin as…
Share
BitcoinEthereumNews2025/09/18 00:27